Charles River Laboratories International (CRL) Cash from Investing Activities Growth (3y) (2012 - 2026)
Powered by 
Analysis
Charles River Laboratories International (CRL) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 13.86% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -41.30% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -38.69% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 33.27% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 9.04% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 44.03% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 56.50% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 27.63% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 33.27% |
| Mar 28, 2026 | -34.23% |
| Dec 27, 2025 | -59.94% |
| Sep 27, 2025 | 28.50% |
| Jun 28, 2025 | 56.77% |
| Mar 29, 2025 | 22.58% |
| Dec 28, 2024 | -116.71% |
| Sep 28, 2024 | 60.84% |
| Jun 29, 2024 | 59.83% |
| Mar 30, 2024 | 14.65% |
| Dec 30, 2023 | -39.18% |
| Sep 30, 2023 | -3.96% |
| Jul 1, 2023 | -38.84% |
| Apr 1, 2023 | 25.86% |
| Dec 31, 2022 | 37.97% |
| Sep 24, 2022 | -14.51% |
| Jun 25, 2022 | 4.37% |
| Mar 26, 2022 | -67.61% |
| Dec 25, 2021 | 28.69% |
| Sep 25, 2021 | -120.74% |